• 제목/요약/키워드: Multiplicity of infection

검색결과 45건 처리시간 0.031초

Sulforhodamine B Assay to Determine Cytotoxicity of Vibrio vulnificus Against Human Intestinal Cells

  • Lee, Byung-Cheol;Choi, Sang-Ho;Kim, Tae-Sung
    • Journal of Microbiology and Biotechnology
    • /
    • 제14권2호
    • /
    • pp.350-355
    • /
    • 2004
  • Sulforhodamine B (SRB) assay is a rapid, sensitive, and inexpensive method for measuring cell proliferation and chemosensitivity. However, the lactate dehydrogenase (LDH) release assay is generally used to measure cytototoxicity of infectious microorganisms against host cells. In this study, we investigated the possibility of applying the SRB assay to determine cytotoxicity for infectious microorganisms, and compared the results with those obtained by the LDH release assay. We used Vibrio vulnificus as a model of infectious microorganisms. The SRB assay showed that V vulnificus strongly induced cytotoxic activity against human intestinal cells, Caco-2 and INT-407 cells. The degree of cytotoxicity closely correlated with infection time and number ratios of V. vulnificus to intestinal cells (MOI, multiplicity of infection). Furthermore, cytotoxicity values obtained by SRB assay correlated well with results obtained by the LDH release assay, and both assays gave a linear response with respect to MOI Heat-inactivation of V. vulnificus for 35 min at $60^{\circ}C$ did not induce cytotoxic activity, indicating that viability of V. vulnificus is crucial for cytotoxic activity against intestinal cells. Although both assays are suitable as cytotoxicity endpoints, the SRB assay is recommended for measuring cytotoxicity of infectious microorganisms against host cells because of its significantly lower cost and more stable endpoint than the LDH release assay.

수두 바이러스 증식에 미치는 혈청의 영향 (Effect of Serum on Varicella-Zoster Virus Propagation)

  • 전복환;우규진
    • KSBB Journal
    • /
    • 제9권3호
    • /
    • pp.272-278
    • /
    • 1994
  • 약독화된 수두 바이러스(Varicella-zoster virus: VZV)를 샤람 폐세포(human embryonic lung c cells)에서 배양하였으며, 수두 바이러스의 생산에 미치는 혈청의 종류와 농도의 효과를 조샤하였다. 수두 바이러스는 바이러스 감염 비율이 높을수록 높 은 역가를 보였으며, 배양시간이 경과함에 따라 바 이러스 감염된 세포의 파괴로 인하여 세포수가 감소 되었다 .. Newborn calf serum(NCS), calf serum (CS), horse serum(HS) 등의 혈청을 샤용한 배양에서의 수두 바이러스의 역가는 CSis와 FBS를 사 용한 배양에서보다 낮아서 수두 바이러스 생산을 증 가하기 위해 이들 혈청의 사용은 적합하지 못하였 다. 그러나, calf serum iron supplemented(CSis) 혈청을 첨가한 배지에서의 세포 친화 바이러스(cell­a associated virus)와 세포 유리 바이러스( cell-free v virus)수율은 fetal bovine serum(FBS)을 첨가한 배지에서의 수율과 비슷하였으며, 고농도의 혈청사 용은 고려되어져야 할 요소이었다. 또한, 수두 바이 러스의 증식 벚 감염력 유지가 혈청성분과 농도에 의해서 영향을 받고 있음을 보였다.

  • PDF

수지상세포의 CD1b 분자와 포식작용의 증가 (CD1b in immature dendritic cells acquires increased phagocytotic function)

  • 류현정
    • 미생물학회지
    • /
    • 제54권3호
    • /
    • pp.222-227
    • /
    • 2018
  • CD1 분자는 결핵균 유래 지질항원 발현하는 단백질이며, 특히 수지상세포(dendritic cells)가 결핵균 감염시에 발현이 점차 감소함을 관찰하였다. 이는 결핵균의 사균이나 항원만으로는 관찰되지 않는 결과였다. 2차원 전기영동(2D electrophoresis)을 통하여 CD1b 의 인산화를 관찰하였고 이러한 현상이 식세포작용과 연관됨을 확인하였다.

아데노 바이러스 Cytosine Deaminase/Thymidine Kinase 융합 유전자의 항 종양효과 (Antitumor Effect of an Adenoviral Cytosine Deaminase/Thymidine Kinase Fusion Gene in C6 Glioma Cells)

  • 김영우;최재영;장진우;박용구;정상섭
    • Journal of Korean Neurosurgical Society
    • /
    • 제30권sup1호
    • /
    • pp.13-19
    • /
    • 2001
  • Objective : We investigated the feasibility of a double suicide gene/prodrug therapy, involving direct introduction of the herpes simplex virus Type 1 thymidine kinase(TK) gene and the Escherichia coli cytosine deaminase(CD) gene, via a recombinant adenoviral vector and ganciclovir(GCV) and/or 5-fluorocytosine(5-FC) treatment, in C6 glioma cells. Methods : Efficient gene transfer and transduction of C6 glioma cells via a recombinant adenovirus were evaluated by infecting cells with adenovirus bearing the ${\beta}$-galactosidase gene and then staining cells with 5-bromo-4-chloro-3-indolyl-13-D-galactoside. CD/TK expression in cells infected with adenovirus bearing the CD/TK gene(ad-CD/TK) was examined by immunoblotting analysis. For in vitro cytotoxicity experiments, the cells were infected with ad-CD/TK or ad-${\Delta}E1$(as a control). After addition of a variety of concentrations of GCV and 5-FU, either separately or in combination, cell viability was determined by staining the cells with crystal violet solution 6 days after infection. Result : C6 glioma cells were efficiently transduced with recombinant adenoviral vector at multiplicities of infection of 200 or more. In vitro cytotoxicity of GCV and/or 5-FC, either alone or in combination, was exclusively observed in the cells transduced with ad-CD/TK. Obvious cytotoxicity(>50% inhibition) was observed in the presence of 5-FC at concentrations greater than 30ug/ml or GCV at concentrations greater than 0.3ug/ml at a multiplicity of infection of 100. Additionally, cytotoxicity in the presence of both GCV and 5-FC was greater than that after sinlge-prodrug treatments, indicating additive effects of the prodrug treatments. Conclusion : The administration of a double-suicide gene/prodrug therapy might have great potential in the treatment of brain tumors.

  • PDF

Molecular Aspects of Japanese Encephalitis Virus Persistent Infection in Mammalian Cells

  • Park Sun-Hee;Won Sung Yong;Park Soo-Young;Yoon Sung Wook;Han Jin Hyun;Jeong Yong Seok
    • 한국미생물학회:학술대회논문집
    • /
    • 한국미생물학회 2000년도 International Meeting 2000
    • /
    • pp.23-36
    • /
    • 2000
  • Japanese encephalitis virus (JEV) is the causative agent of a mosquito-borne encephalitis and is transmitted to human via persistently infected mosquito vectors. Although the virus is known to cause only acute infection, there were reports that showed neurological sequelae, latent infection in peripheral mononuclear cells, and recurrence of the disease after acute encephalitis. Innate resistance of certain cell lines, abnormal SN1 expression of the virus, and anti-apoptotic effect of cullular bcl-2 have been suggested as probable causes of JEV persistence even in the absence of defective interfering (DI) particles. Although possible involvement of DI particles in JEV persistence was suggested, neither has a direct evidence for DI presence nor its molecular characterization been made. Two questions asked in this study are whether the DI virus plays any role in JEV persistent infection if it is associated with and what type of change(s) can be made in persistently infected cells to avoid apoptosis even with the continuous virus replication, DI-free standard stock of JEV was infected in BHK-21, Vero, and SW13 cells and serial high multiplicity passages were performed in order to generate DI particles. There different-sized DI RNA species which were defective in both structural and nonstructural protein coding genes. Rescued ORFs of the DI genome maintained in-frame and the presence of replicative intermediate or replicative form RNA of the DI particles confirmed their replication competence. On the other hand, several clones with JEV persistent infection were established from the cells survived acute infections during the passages. Timing of the DI virus generation during the passages seemed coincide to the appearance of persistently infected cells. The DI RNAs were identified in most of persistently infected cells and were observed throughout the cell maintenance. One of the cloned cell line maintained the viral persistence without DI RNA coreplication. The cells with viral persistence released the reduced but continuous infectious JEV particle for up to 9 months and were refractory to homologous virus superinfection but not to heterologous challenges. Unlike the cells with acute infection these cells were devoid of characteristic DNA fragmentation and JEV-induced apoptosis with or without homologous superinfection. Therefore, the DI RNA generated during JEV undiluted serial passage on mammalian cells was shown to be biologically active and it seemed to be responsible, at least in part, for the establishment and maintenance of the JEV persistence in mammalian cells. Viral persistence without DI RNA coreplication, as in one of the cell clones, supports that JEV persistent infection could be maintained with or without the presence of DI particles. In addition, the fact that the cells with JEV persistence were resistant against homologous virus superinfection, but not against heterologous one, suggests that different viruses have their own and independent pathway for cytopathogenesis even if viral cytopathic effect could be converged to an apoptosis after all.

  • PDF

두 가지 곤충 세포주에 대한 배양 및 바이러스 증식을 위한 최적 FBS 농도 결정 (Determination of the Optimal Concentration of Fetal Bovine Serum for the Growth of Two Insect Cell and Viruses)

  • 이재경;구현나;우수동
    • 한국응용곤충학회지
    • /
    • 제46권2호
    • /
    • pp.319-324
    • /
    • 2007
  • 곤충 세포주 Sf21과 Bm5 세포주에 대해 세포 배양과 바이러스의 증식을 위한 최적 FBS 의 농도를 결정하기 위하여 다양한 FBS 농도에서 세포 및 바이러스의 증식 곡선을 비교하였다. 세포의 생존율, 증식속도, 증식량 그리고 FBS 함량을 모두 고려할 때 Sf21 에 대해서는 7%가, Bm5에 대해서는 5% FBS 가 최적 농도로 결정되었다. 바이러스의 증식은 감염 후 5일째에 두 세포주 모두 모든 FBS 농도에서 유사한 증식량을 보였으나, 감염 후 2 일과 3일에 있어서는 Sf21 은 각각 10%와 3%가 Bm5 에 대해서는 양일 모두 5% FBS 농도에서 가장 증식량이 높았다. 이러한 결과는 목적에 따라 세포 및 바이러스 증식을 위한 적정 FBS 농도의 결정이 필요함을 제시하는 것이다.

초파리 S2 세포 시스템에서 녹색형광단백질 생산을 위한 재조합 배큘로바이러스의 감염조건들의 영향 (Effects of Recombinant Baculovirus Infection Conditions on Production of Green Fluorescent Protein in Drosophila S2 Cells)

  • 조혜숙;김연규;김경로;차형준
    • Korean Chemical Engineering Research
    • /
    • 제44권1호
    • /
    • pp.40-45
    • /
    • 2006
  • 원하는 유전자를 배큘로바이러스의 감염에 의하여 초파리 Drosophila melanogaster S2 세포에 도입하는 배큘로바이러스/S2 세포 발현 시스템은 강력하고 안전한 배큘로바이러스의 장점과 세포가 파괴되지 않는 S2 세포의 장점을 접목한 시스템이다. 본 연구에서는 외래 목적 단백질로 발현 모니터링이 손쉬운 녹색형광단백질(green fluorescent protein)을 발현시키는 재조합 배큘로바이러스를 이용하여 S2 세포에의 감염조건들에 대한 영향 연구를 수행하였다. 재조합 배큘로바이러스의 S2 세포에의 감염조건으로는 multiplicity of infection(MOI), 초기 세포 수, 배큘로바이러스 용액이 세포를 적시는 최소 부피, 배큘로바이러스를 첨가한 후 제거하기까지의 배양시간 그리고 배큘로바이러스 제거 후 S2 세포를 혈청이 존재하는 배지에서 키우는 배양시간을 선정하였다. MOI는 일반적으로 크게 하는 것이 높은 발현 수율을 위하여 좋은 결과를 보였으나 세포배양이 길어지는 경우 세포독성의 문제가 심각해 질 수 있고 실제적인 배양에서는 높은 MOI를 유지하는 것이 불가능하므로 사용하는 100 mm 배양접시에서 배큘로바이러스와 S2 세포가 접촉하는 동안의 변수들인 MOI를 적정의 값인 30으로, 배큘로바이러스 배양 시간을 1.5 시간으로 고정함으로써 배큘로바이러스가 숙주 세포인 S2에 대해 미치는 세포독성을 낮출 수 있었다. 또한, 배큘로바이러스 최소 부피는 배양접시에서 사용부피의 2.4%에서 가장 좋은 결과를 보였으며 배큘로바이러스 용액을 10배 농축시킴으로써 이 부피를 맞추기 위해 첨가시키는 새로운 배지의 비율을 높임으로써 결과적으로 배큘로바이러스에 의한 세포독성을 줄일 수 있었다. 이를 통하여 세포 파쇄 및 배양접시 표면에서 탈착되는 것을 막고 높은 생장 상태를 유지해서 감염 효율도 높일 수 있었다. 배큘로바이러스의 감염이 끝난 후의 관여하는 변수들인 감염 후 배양시간은 24시간에서 최대의 녹색형광단백질의 발현을 나타내었다.

Optimal Conditions for the Expression of Glycoprotein E2 of Classical Swine Fever Virus using Baculovirus in Insect Cells

  • Bae, Sung Min;Lee, Seung Hee;Kwak, Won Suk;Ahn, Yong Oh;Shin, Tae Young;Woo, Soo Dong
    • International Journal of Industrial Entomology and Biomaterials
    • /
    • 제29권2호
    • /
    • pp.207-213
    • /
    • 2014
  • The structural proteins of classical swine fever virus (CSFV) consist of nucleocapsid protein C and envelope glycoprotein $E^{rns}$ (E0), E1 and E2. Among them, E2, the most immunogenic of the CSFV glycoproteins, induces a protective immune response in swine. In this study, to determine the optimal expression conditions of glycoprotein E2 using baculovirus system, we investigated the influence of insect cells and media to the expression of recombinant E2. Recombinant virus containing glycoprotein E2 coding gene was constructed with bApGOZA DNA. Expression of the glycoprotein E2 was analyzed by SDS-PAGE and Western blot analysis using anti-CSFV E2 monoclonal antibodies. Expression of glycoprotein E2 in Sf21 cells was first observed after 3 days and reached a maximum on the 5th day after infection. Furthermore, the highest levels of glycoprotein E2 expression were observed at multiplicity of infection (MOI) of 5. When three different insect cell lines (Sf21, High-Five and Se301) were tested, High-Five cells showed the highest production. In addition, four different serum-free and serum-supplemented media, respectively, were tested for the expression of glycoprotein E2 and the budded virus (BV) titers. As a result, serum-supplemented medium provided the best conditions for protein production and the BV yield.

Efficient Production of Porcine Circovirus Type 2 Capsid Protein using Baculovirus

  • Lee, Jun-Beom;Bae, Sung-Min;Kim, Hee-Jung;Lee, Won-Woo;Heo, Won-Il;Shin, Tae-Young;Choi, Jae-Bang;Woo, Soo-Dong
    • International Journal of Industrial Entomology and Biomaterials
    • /
    • 제24권1호
    • /
    • pp.23-27
    • /
    • 2012
  • Porcine circovirus type 2 (PCV2) is a single-stranded circular DNA virus associated with Postweaning multisystemic wasting syndrome (PMWS), which is considered to be an important infectious swine viral disease. PCV2 capsid protein encoded by ORF2 is a structural protein and expected as the high immunogenicity protein. In this study, we generated recombinant baculovirus containing ORF2 of PCV2 and analyzed the optimal conditions for the production of capsid protein in insect cell. Production and status of recombinant capsid protein in insect cell were confirmed by SDS-PAGE and Western blot analysis using His tag antibody and anti-PCV2 serum. The yield of recombinant capsid protein was high like as shown visible on SDS-PAGE. Optimal multiplicity of infection (MOI) and infection time of recombinant virus were determined as 5 MOI and 4 days, respectively. ORF2 is known to have N-linked glycosylation site, but we couldn't detect the glycosylation of recombinant protein in insect cells.

Plasmodium falciparum Genotype Diversity in Artemisinin Derivatives Treatment Failure Patients along the Thai-Myanmar Border

  • Congpuong, Kanungnit;Hoonchaiyapoom, Thirasak;Inorn, Kornnarin
    • Parasites, Hosts and Diseases
    • /
    • 제52권6호
    • /
    • pp.631-637
    • /
    • 2014
  • Genetic characteristics of Plasmodium falciparum may play a role in the treatment outcome of malaria infection. We have studied the association between diversity at the merozoite surface protein-1 (msp-1), msp-2, and glutamate-rich protein (glurp) loci and the treatment outcome of uncomplicated falciparum malaria patients along the Thai-Myanmar border who were treated with artemisinin derivatives combination therapy. P. falciparum isolates were collected prior to treatment from 3 groups of patients; 50 cases of treatment failures, 50 recrudescences, and 56 successful treatments. Genotyping of the 3 polymorphic markers was analyzed by nested PCR. The distribution of msp-1 alleles was significantly different among the 3 groups of patients but not the msp-2 and glurp alleles. The allelic frequencies of K1 and MAD20 alleles of msp1 gene were higher while RO33 allele was significantly lower in the successful treatment group. Treatment failure samples had a higher median number of alleles as compared to the successful treatment group. Specific genotypes of msp-1, msp-2, and glurp were significantly associated with the treatment outcomes. Three allelic size variants were significantly higher among the isolates from the treatment failure groups, i.e., $K1_{270-290}$, $3D7_{610-630}$, $G_{650-690}$, while 2 variants, $K1_{150-170}$, and $3D7_{670-690}$ were significantly lower. In conclusion, the present study reports the differences in multiplicity of infection and distribution of specific alleles of msp-1, msp-2, and glurp genes in P. falciparum isolates obtained from treatment failure and successful treatment patients following artemisinin derivatives combination therapy.